These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 23677869)

  • 21. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds.
    Klouda L; Vaz CM; Mol A; Baaijens FP; Bouten CV
    J Mater Sci Mater Med; 2008 Mar; 19(3):1137-44. PubMed ID: 17701317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1.
    Dvorin EL; Wylie-Sears J; Kaushal S; Martin DP; Bischoff J
    Tissue Eng; 2003 Jun; 9(3):487-93. PubMed ID: 12857416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An in vitro model system to quantify stress generation, compaction, and retraction in engineered heart valve tissue.
    van Vlimmeren MA; Driessen-Mol A; Oomens CW; Baaijens FP
    Tissue Eng Part C Methods; 2011 Oct; 17(10):983-91. PubMed ID: 21609192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of poly-glycolic acid-based hybrid polymer starter matrices for in vitro tissue engineering.
    Generali M; Kehl D; Capulli AK; Parker KK; Hoerstrup SP; Weber B
    Colloids Surf B Biointerfaces; 2017 Oct; 158():203-212. PubMed ID: 28697435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly-ε-caprolactone scaffold and reduced in vitro cell culture: beneficial effect on compaction and improved valvular tissue formation.
    Brugmans MM; Driessen-Mol A; Rubbens MP; Cox MA; Baaijens FP
    J Tissue Eng Regen Med; 2015 Dec; 9(12):E289-301. PubMed ID: 23677869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing Biocompatible Tissue Engineered Heart Valves In Situ: JACC Review Topic of the Week.
    Cordoves EM; Vunjak-Novakovic G; Kalfa DM
    J Am Coll Cardiol; 2023 Mar; 81(10):994-1003. PubMed ID: 36889879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Status of Tissue Engineering Heart Valve.
    Shinoka T; Miyachi H
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Strategies to choose scaffold materials for tissue engineering].
    Gao Q; Zhu X; Xiang J; Lü Y; Li J
    Sheng Wu Gong Cheng Xue Bao; 2016 Feb; 32(2):172-84. PubMed ID: 27382767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Materials and manufacturing perspectives in engineering heart valves: a review.
    Oveissi F; Naficy S; Lee A; Winlaw DS; Dehghani F
    Mater Today Bio; 2020 Jan; 5():100038. PubMed ID: 32211604
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.